Applied DNA Sciences Inc (APDN)
0.4212
+0.01
(+3.36%)
USD |
NASDAQ |
Jun 27, 16:00
0.4212
0.00 (0.00%)
After-Hours: 20:00
Applied DNA Sciences Gross Profit (Quarterly): 0.2957M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.2957M |
December 31, 2023 | 0.2311M |
September 30, 2023 | 0.079M |
June 30, 2023 | 1.269M |
March 31, 2023 | 1.807M |
December 31, 2022 | 2.378M |
September 30, 2022 | 0.4168M |
June 30, 2022 | 1.039M |
March 31, 2022 | 2.488M |
December 31, 2021 | 1.109M |
September 30, 2021 | 1.067M |
June 30, 2021 | 0.5842M |
March 31, 2021 | 1.731M |
December 31, 2020 | 1.100M |
September 30, 2020 | 0.0526M |
June 30, 2020 | 0.2767M |
March 31, 2020 | 0.3729M |
December 31, 2019 | 0.4015M |
September 30, 2019 | 1.353M |
June 30, 2019 | 1.783M |
March 31, 2019 | 0.6453M |
December 31, 2018 | 0.7308M |
September 30, 2018 | 0.9447M |
June 30, 2018 | 0.7638M |
March 31, 2018 | 0.6718M |
Date | Value |
---|---|
December 31, 2017 | 0.3162M |
September 30, 2017 | 0.8728M |
June 30, 2017 | 1.565M |
March 31, 2017 | 0.608M |
December 31, 2016 | 0.6282M |
September 30, 2016 | 1.201M |
June 30, 2016 | 0.4723M |
March 31, 2016 | 0.3196M |
December 31, 2015 | 1.140M |
September 30, 2015 | 3.725M |
June 30, 2015 | 2.139M |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.0526M
Minimum
Sep 2020
2.488M
Maximum
Mar 2022
0.9918M
Average
1.053M
Median
Gross Profit (Quarterly) Benchmarks
Fonar Corp | 11.75M |
XWELL Inc | 2.671M |
ProPhase Labs Inc | -0.433M |
Veracyte Inc | 65.38M |
OncoCyte Corp | -0.098M |